Pharmacology Case Studies: Hypertension, Dyslipidemia, Asthma & COPD
This paper presents four pharmacology case studies addressing common chronic conditions encountered in clinical practice. The first case examines a patient with persistent hypertension managed with amlodipine and lifestyle modifications. The second addresses dyslipidemia and coronary artery disease risk in a smoker treated with atorvastatin. The third case focuses on uncontrolled asthma requiring a step-up in therapy to a fluticasone/salmeterol combination inhaler. The fourth case covers COPD progression in a patient with poor medication adherence and a significant smoking history. Each scenario identifies the clinical problem, sets treatment goals, provides a specific prescription, outlines monitoring strategies, and includes patient education recommendations grounded in current clinical guidelines.
- Scenario 1: Hypertension Management: Amlodipine prescription and lifestyle education for hypertension
- Scenario 2: Dyslipidemia and Coronary Artery Disease Risk: Atorvastatin therapy and CAD risk factor review
- Scenario 3: Asthma Management: Step-up asthma therapy with fluticasone/salmeterol combination
- Scenario 4: Chronic Obstructive Pulmonary Disease (COPD) Management: COPD treatment reinitiation and smoking cessation support
- References: APA citations for all clinical guidelines cited
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Each case study follows a consistent, clinically structured format — problem identification, goal-setting, prescription, and monitoring — mirroring real-world SOAP note logic and making the paper easy to navigate.
- Prescriptions are specific and actionable (drug name, dose, route, frequency), demonstrating applied pharmacological knowledge rather than vague generalizations.
- The paper integrates authoritative guidelines (AHA/ACC, NICE, GINA, GOLD) to justify each treatment decision, showing evidence-based clinical reasoning.
Key academic technique demonstrated
This paper demonstrates the application of guideline-based clinical reasoning to individual patient scenarios. Rather than simply reciting pharmacological facts, the author maps each patient's specific risk profile — comorbidities, smoking history, medication interactions, symptom burden — to the appropriate first-line therapy recommended by major professional organizations. This technique of linking patient characteristics to guideline criteria is a core competency in graduate-level clinical pharmacology and advanced practice nursing education.
Structure breakdown
The paper is organized into four parallel case study sections, each subdivided into problem, goals, prescription, monitoring, and education or risk factor subsections. A consolidated reference list in APA format closes the paper. The parallel structure allows readers to compare clinical reasoning across different disease states while reinforcing a consistent problem-solving methodology.
Scenario 1: Hypertension Management
The patient presents with persistently high blood pressure (hypertension), indicated by her current reading of 160/90 mmHg and her previous reading of 156/92 mmHg three months ago. Considering her weight and ongoing use of ibuprofen — a medication that can elevate blood pressure — addressing her hypertension is critical (National Institute for Health and Care Excellence, 2019).
According to the American College of Cardiology and the American Heart Association, the goal is to reduce the patient's blood pressure to below 130/80 mmHg in order to minimize her risk of cardiovascular disease (Whelton et al., 2018).
Given her hypertension and current use of ibuprofen, which can contribute to increased blood pressure, a calcium channel blocker or a thiazide diuretic could be considered. Based on her clinical profile, amlodipine — a calcium channel blocker — is a suitable choice due to its efficacy and favorable safety profile.
Prescription: Amlodipine 5 mg, oral, once daily. Take one tablet by mouth once daily.
The clinician should discuss the potential impact of ibuprofen on blood pressure and explore alternative options for back pain management. Emphasis should be placed on the importance of lifestyle modifications, including a diet low in sodium, regular physical activity, and weight loss to help manage hypertension. The patient should also be advised on the importance of monitoring blood pressure regularly (Chobanian et al., 2003).
Scenario 2: Dyslipidemia and Coronary Artery Disease Risk
The patient's lipid profile indicates dyslipidemia, with elevated total cholesterol, LDL cholesterol, and triglycerides, and low HDL cholesterol. He is also a smoker, which adds significantly to his risk for coronary artery disease (CAD) (National Institute for Health and Care Excellence, 2014).
According to the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol, the addition of a statin is recommended to manage the patient's lipid levels, particularly to lower his LDL cholesterol (Grundy, 2019).
The treatment goals are to reduce total cholesterol (TC) to below 200 mg/dL, reduce LDL-C to below 100 mg/dL (recommended for individuals at high risk), and increase HDL-C to above 40 mg/dL.
Prescription: Atorvastatin 20 mg, oral, once daily. Take one tablet by mouth once daily at bedtime.
A follow-up lipid profile should be obtained in 4–12 weeks to assess response and adherence, then every 3–12 months as needed. The patient should be monitored for potential statin side effects, including muscle pain or weakness.
Risk factors for coronary artery disease in this patient include smoking, hypertension (inferred from the clinical context and medication history), dyslipidemia, and age greater than 45 years in men (Greenland et al., 2010).
Always verify citation format against your institution’s current style guide requirements.